Albany Molecular Research Inc $16.09

up +0.02


17/4/2014 08:10 PM  |  NASDAQ : AMRI  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AMRI Trend Analysis - it has outperformed the S&P 500 by 57%

Partner Headlines

  1. Mid-Afternoon Market Update: Markets Post a Large Rally as Intuitive Surgical ...

    Benzinga
  2. Mid-Day Market Update: Alcoa Surges On Upbeat Earnings; Intuitive Surgical ...

    Benzinga
  3. Mid-Morning Market Update: Markets Open Higher; Constellation Brands Profit ...

    Benzinga
  4. Stocks To Watch For April 7, 2014

    Benzinga
  5. AMRI Completes Acquisition of Cedarburg Pharmaceuticals, Inc

    Benzinga
  6. US Stock Futures Up Ahead Of Manufacturing PMI

    Benzinga
  7. Mid-Day Market Update: Nike Drops On Cautious Forecast; Endocyte Shares ...

    Benzinga
  8. Benzinga's Top Downgrades

    Benzinga
  9. UPDATE: Sterne Agee Downgrades Albany Molecular Research on Less Optimism ...

    Benzinga
  10. AMRI Wins Development, Manufacture Contract from the UK Gov't, Provides ...

    Benzinga
  11. AMRI Names William S. Marth as President and CEO

    Benzinga
  12. UPDATE: Albany Molecular Research Shares Down Roughly 20% At $10.27, Fell ...

    Benzinga
  13. Albany Molecular Files Form 8-K Disclosing Termination Of Development Of ...

    Benzinga
  14. A Peek Into The Market Before The Trading Starts

    Benzinga
  15. AMRI Announces Deal for Exclusive Rights to Tubulin Inhibitor Program for ...

    Benzinga
  16. AMRI Names Saffee VP of Large Scale Manufacturing

    Benzinga
  17. AMRI Realigns Discovery Services to Support Customer Demand

    Benzinga
  18. Stocks Hitting 52-Week Highs

    Benzinga
  19. Albany Molecular Research, Inc. (AMRI) CEO Ambra Thomas E Phd D buys 1 ...

    GuruFocus
  20. Albany Molecular Research Inc. Reports Operating Results (10-Q)

    GuruFocus
  21. Albany Molecular Research Inc. Reports Operating Results (10-Q)

    GuruFocus
  22. Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN

    GuruFocus
Trading Center